CASR and neoplasm: Colloton and coworkers investigated the ability of cinacalcet, an allosteric modulator of CaSR, to attenuate hypercalcemia in mice bearing H-500 cells and indeed demonstrated that cinacalcet effectively reduced tumor-mediated hypercalcemia (Colloton et al., 2013).